PT - JOURNAL ARTICLE AU - Brian L. Edlow AU - Megan E. Barra AU - David W. Zhou AU - Samuel B. Snider AU - Zachary D. Threlkeld AU - John E. Kirsch AU - Suk-tak Chan AU - Steven L. Meisler AU - Thomas P. Bleck AU - Joseph J. Fins AU - Joseph T. Giacino AU - Leigh R. Hochberg AU - Ken Solt AU - Emery N. Brown AU - Yelena G. Bodien TI - Personalized Connectome Mapping to Guide Targeted Therapy and Promote Recovery of Consciousness in the Intensive Care Unit AID - 10.1101/19013987 DP - 2019 Jan 01 TA - medRxiv PG - 19013987 4099 - http://medrxiv.org/content/early/2019/12/09/19013987.short 4100 - http://medrxiv.org/content/early/2019/12/09/19013987.full AB - There are currently no therapies proven to promote early recovery of consciousness in patients with severe brain injuries in the intensive care unit (ICU). Early recovery of consciousness would benefit patients and families by reducing the likelihood of premature withdrawal of life-sustaining therapy and may decrease ICU complications related to immobility, facilitate self-expression, enable autonomous decision-making, and increase access to rehabilitative care. Here, we present the connectome-based clinical trial platform (CCTP), a new mechanistic paradigm for developing and testing targeted therapies that promote early recovery of consciousness in the ICU. The scientific premise of the CCTP is that personalized brain connectome maps can be used to select patients for targeted therapies that promote recovery of consciousness. Structural and functional MRI connectome maps will identify circuits that may be amenable to neuromodulation. Patients will be selected for clinical trials in the CCTP paradigm based on connectomes that are likely to respond to targeted therapies. To demonstrate the utility of this precision approach, we describe STIMPACT (Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness), a CCTP-based clinical trial in which intravenous methylphenidate will be used to promote early recovery of consciousness in the ICU (ClinicalTrials.gov NCT03814356). We propose that the CCTP has the potential to transform the therapeutic landscape in the ICU and improve outcomes for patients with severe brain injuries.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03814356Funding StatementThe study was funded by the NIH Director’s Office (DP2HD101400), National Institute of Neurological Disorders and Stroke (K23NS094538, R21NS109627, RF1NS115268), American Academy of Neurology/American Brain Foundation, James S. McDonnell Foundation, Rappaport Foundation, and Tiny Blue Dot Foundation. We also acknowledge support from the National Institute of Neurological Disorders and Stroke Clinical Trial Methodology Course (R25NS088248). This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData processing scripts can be found at: github.com/ComaRecoveryLab/AAN-in-Acute-Traumatic-Disorders-of-Consciousness.git. The conditions of our Institutional Review Board ethics approval do not permit public archiving of anonymized study data. Readers seeking access to the data should contact the corresponding author.